Mutual of America Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Other funds holding XENE
SL
N
Mutual of America Capital Management's XENE Position: Q2 2026 in Review
Mutual of America Capital Management reduced its Xenon Pharmaceuticals (XENE) stake by 5.2% in Q2 2026, selling an estimated $333K and leaving 109,603 shares worth $6.62M. The position accounts for 0.06% of the portfolio, ranked #337.
Mutual of America Capital Management first reported a position in XENE in Q1 2025 and has held it in 6 quarters since. The position peaked at $6.72M in Q1 2026. 173 funds tracked by Wall St. Rank hold XENE as of Q2 2026.
- Mutual of America Capital Management held 109,603 shares of Xenon Pharmaceuticals worth $6.62M as of Q2 2026.
- Mutual of America Capital Management sold 5,991 Xenon Pharmaceuticals shares in Q2 2026, an estimated $333K.
- Xenon Pharmaceuticals made up 0.06% of Mutual of America Capital Management's portfolio in Q2 2026, its #337 holding.
- Mutual of America Capital Management first reported a position in Xenon Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
- Mutual of America Capital Management's Xenon Pharmaceuticals position peaked at $6.72M in Q1 2026.
- 173 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.
Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.